(AOF) – Equasens, the specialist in IT solutions for healthcare professionals, revealed stable turnover at 50.1 million euros in the third quarter of 2023. The increase in turnover is impacted by the end of the deployment of Segur-referenced solutions and a rather gloomy economic situation in the Pharmacy sector. Over 9 months, revenues increased by 6% to 162.70 million euros
The Medical Solutions Division posted a turnover of 1.8 million euros, down 24% compared to the 3rd quarter of 2022. This decline is explained by the end, in the first half of 2023, of Medistory 4 license sales. linked to the Segur deployment, started in the third quarter of 2022.
The Pharmagest Division recorded a turnover of 36.8 million euros, down 1%.
© 2023 Agence Option Finance (AOF) – All reproduction rights reserved by AOF. AOF collects its data from the sources it considers the safest. However, the reader remains solely responsible for their interpretation and use of the information made available to them. The reader must therefore hold AOF and its contributors harmless from any claim resulting from this use. Agence Option Finance (AOF) is a brand of the Option Finance group
Did you like this article ? Share it with your friends using the buttons below.
